Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
By Marc A. F. De Hert, Christoph U. Correll, J. Bobes, M. Cetkovich-Bakmas, D. Cohen, Itsuo Asai, J. Detraux, S. Gautam, Hans-Jürgen Möller, D. Ndetei and 3 more. World Psychiatry, 2011
2,329 citations recorded by the source corpus.
Subfields: Biological Psychiatry, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/611c371ce31e6dedc3d58ef6f711b7a21edbc450
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Psychiatry and Mental health
Citations in the corpus
- The future of mental health care: peer-to-peer support and social media (2016, neutral): “…reach individuals with serious mental illness, it is necessary to overcome barriers such as social isolation, reluctance to use formal health care services and challenging social circumstances such as traumatic life events or disruptive home environments (RachBeisel et al. 1999; Hert et al. 2011).”
- Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis (2015, background): “Factors predisposing people with SMI to CVD include antipsychotic medication and unhealthy lifestyles (7) as well as their reduced likelihood to receive standard levels of medical care (8-12).”
- Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder (2015, methodology): “Among the first-generation antipsychotics (FGAs), the so-called low-potency agents, such as chlorpromazine and thioridazine, have higher weight gain potential than the high-potency drugs, such as haloperidol (11,30).”
- Excess Mortality, Causes of Death and Life Expectancy in 270,770 Patients with Recent Onset of Mental Disorders in Denmark, Finland and Sweden (2013, background): “[33] The European Psychiatric Association (EPA), the European Association for the Study of Diabetes (EASD) and European Society of Cardiology (ESC) have signed a common document with recommendations for monitoring markers of increased risk for metabolic syndrome and cardiovascular diseases.”
- Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta‐analysis (2016, background): “Major risk factors include antipsychotic medication use and an unhealthy lifestyle (7), and these risks are compounded by obstacles in access to medical care (8-12).”
- Risks of all‐cause and suicide mortality in mental disorders: a meta‐review (2014, background): “National strategies could and should target improving access to physical health care (59).”